Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04251819 · ClinicalTrials.gov registry record · Phase 2
Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- Phase 2
- Development phase
- 19
- Enrollment target
NCT04251819 is a Phase 2 study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 19 participants.
The verdict
NCT04251819, a Phase 2 study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 19 participants
- Enrollment target
Study Summary
To determine if baclofen will enhance buprenorphine analgesia for acute pain in healthy volunteers.
Interventions
- DRUG Placebos
- DRUG Baclofen 5 mg
- DRUG Baclofen 10mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2024-06-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04251819
The ClinicalTrials.gov registry entry for NCT04251819 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebos is the first listed.
NCT04251819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04251819 about?
NCT04251819 is a clinical study titled "Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers". To determine if baclofen will enhance buprenorphine analgesia for acute pain in healthy volunteers.
What is the current status of trial NCT04251819?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2021-01-21. Estimated completion is 2024-06-15.
What interventions are being tested in trial NCT04251819?
The interventions under investigation include: Placebos (DRUG), Baclofen 5 mg (DRUG), Baclofen 10mg (DRUG).
Who is sponsoring clinical trial NCT04251819?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.